As pharmaceutical organizations accelerate investments in AI, the conversation is rapidly evolving beyond predictive analytics and automation toward a new era of agentic AI: intelligent systems capable of autonomously orchestrating workflows, supporting decision-making, and driving real-time operational action across manufacturing and supply chain environments. From the plant floor to global network operations, these technologies have the potential to fundamentally reshape how pharmaceutical organizations manage complexity, optimize performance, respond to disruptions, and scale operations. In this forward-looking keynote discussion, Pfizer leaders will explore how agentic AI is beginning to influence the future of pharmaceutical manufacturing and the broader end-to-end supply chain, including where organizations are already seeing practical value, how operating models may evolve, and what challenges still exist around governance, trust, organizational readiness, and change management.

 Understand how agentic AI differs from traditional automation and predictive analytics within pharmaceutical manufacturing and supply chain operations

 Explore emerging use cases where autonomous AI agents can improve visibility, exception management, orchestration, and operational decision-making

 Learn how organizations are preparing their teams, operating models, and digital strategies for the next generation of AI-enabled transformation